spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  epilepsy 

 HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Aug 2022
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 May 2022
Supernus Announces FDA Approval of Qelbree(R) for the Treatment of ADHD in Adults
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Apr 2022
FDA approves Nobelpharma's HYFTOR(TM) (sirolimus topical gel) 0.2%
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 27 Jan 2022
SciSparc Presents New Leadership Lineup
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Nov 2021
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Nov 2021
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense(TM) Data in Rune's Software for Precision Neurology
Devices Neurology
 HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
Devices Neurology FDA
 HSMN NewsFeed - 14 Jun 2021
KT and NeuroSigma Announce Strategic Digital Health Partnership
Devices
 HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology FDA
 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 12 May 2021
Centers for Medicare and Medicaid Services (CMS) Issues Permanent J-Code for Tolmar's FENSOLVI(R) Effective July 1, 2021
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 30 Mar 2021
Biom Therapeutics Receives Orphan Drug Status for BIO017 from the U.S. FDA for the treatment of Angelman Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Mar 2021
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology Regulatory
 HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 2 Nov 2020
Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 5 Jun 2020
UCB Acquires Engage Therapeutics: Staccato(R) Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Devices Drug Delivery Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2020
FDA Approves FENSOLVI(R) (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Nov 2019
Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
Devices Neurology Venture Capital
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 29 Jul 2019
Epygenix Therapeutics Receives IND Approval of EPX-100 for the Treatment of Dravet Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 24 Jun 2019
Allergan Receives FDA Clearance For CoolTone(TM) Device
Devices Dermatology FDA
 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 16 Apr 2019
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Mar 2019
Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 14 Feb 2019
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Jan 2019
Slayback Pharma Announces FDA Approval of Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml in a Multi-Dose Vial, the First Generic Equivalent of Makena(R) Injection 1,250 mg/ 5 ml Multi-Dose Vial
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 27 Sep 2018
Epilepsy Foundation Statement on DEA's Scheduling of Epidiolex(R)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Sep 2018
Neurelis Files New Drug Application with the FDA for VALTOCO(TM) Nasal Spray, an Investigational Treatment for Pediatric, Adolescent and Adult Epilepsy Patients
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 30 Aug 2018
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing
 HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 14 May 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Biopharmaceuticals Drug Delivery Generics Litigation
 HSMN NewsFeed - 20 Apr 2018
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 2 Apr 2018
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jan 2018
Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 28 Dec 2017
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex(R) (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Dec 2017
Elekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting
Devices Radiology Neurology Product Launch
 HSMN NewsFeed - 30 Oct 2017
UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD
Devices Neurology
 HSMN NewsFeed - 15 Sep 2017
New indication for BRIVIACT(R) (brivaracetam): UCB's newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Aug 2017
Epygenix Therapeutics Receives US FDA Orphan Drug Designation for EPX-300 for the Treatment of Patients With Dravet Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Jul 2017
The FDA has Accepted an Orphan Designation Request for use of Truveta Administered Intranasally Submitted by Axium Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Jun 2017
Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 May 2017
Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Apr 2017
Epygenix Therapeutics Receives Orphan Drug Designation From the U.S. FDA for EPX-100 and EPX-200 in the Treatment of Patients With Dravet Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Apr 2017
AMAG Submits Supplemental New Drug Application to FDA for Makena(R) (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 6 Apr 2017
Supernus Receives Final FDA Approval for Trokendi XR(R) for Migraine Prophylaxis in Adults and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Apr 2017
Synchron Inc. Secures $10 Million in Series A Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 7 Mar 2017
Supernus Announces Settlement with Zydus on Trokendi XR(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 1 Feb 2017
Marinus Appoints Michael R. Dougherty to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Jan 2017
Biscayne Announces Formation of Biscayne Neurotherapeutics and Completion of Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 9 Jan 2017
Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2017
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone to Treat Fragile X Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Dec 2016
Supernus Wins Appeal Case on Oxtellar XR(R)
Biopharmaceuticals Neurology Litigation
 HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2016
Insys Therapeutics Announces CEO Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2016
Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate(R) In Patients Newly Diagnosed With Glioblastoma Multiforme
Devices Oncology Neurosurgery FDA
 HSMN NewsFeed - 7 Sep 2016
Marinus Appoints Seth H.Z. Fischer to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Jul 2016
Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jun 2016
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex(R) (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2016
Alexza Pharmaceuticals Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2016
Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR(TM) at the 39th European Cystic Fibrosis Conference
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2016
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2016
Alexza Pharmaceuticals to be Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Apr 2016
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Mar 2016
First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available
Biopharmaceuticals Drug Delivery Neurology Product Launch
 HSMN NewsFeed - 26 Feb 2016
Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 17 Feb 2016
Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2016
Supernus Prevails in Oxtellar XR(R) ANDA Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Jan 2016
FDA Approves Eisai's Halaven(R) (eribulin mesylate) Injection for the Treatment of Patients with Advanced Liposarcoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jan 2016
Mylan Launches Generic Felbatol(R) Tablets
Biopharmaceuticals Generics Neurology Product Launch
 HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2015
VistaGen Secures Exclusive Worldwide Commercial Rights to Three Proprietary Stem Cell Technologies from University Health Network
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 16 Nov 2015
NeuroSigma's Monarch eTNS System Receives CE Mark Approval for ADHD
Devices Neurology Regulatory
 HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology
 HSMN NewsFeed - 22 Oct 2015
Vtesse, Inc. Expands Scientific Advisory Board and Appoints New VP of Clinical Operations to Support Late-Stage Clinical Study of Lead Drug Candidate VTS-270
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger Directors Of Combined Company
Devices Cardiology Neurology Personnel Acquisitions
 HSMN NewsFeed - 20 Aug 2015
Cyberonics and Sorin Provide Merger Update
Devices Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 Aug 2015
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Aug 2015
FDA Approves the First 3D Printed Drug Product
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Devices Neurology Mergers & Acquisitions Personnel
 HSMN NewsFeed - 11 May 2015
GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Apr 2015
SciFluor Life Sciences Raises $30 Million and Names William Koster, PhD, Former CEO of Neurogen Corp., as Chairman
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Mar 2015
GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Feb 2015
Topline Results of Phase 3 Trial Show Eribulin Mesylate Injection Meets Primary Endpoint of Overall Survival in Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Feb 2015
Pivotal Phase 3 Trial of Investigational Agent Lenvatinib in Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer Published in New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
Devices Neurology Personnel
 HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2014
Cyberonics Reports Consistently Positive Results From The E-36 And E-37 Studies For VNS Therapy Delivered By AspireSR(R) Generator
Devices Neurology
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 27 Oct 2014
Zogenix Acquires U.K.-Based Brabant Pharma
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Oct 2014
NeuroSigma Receives Notice of Allowance of U.S. Patent Application
Devices Neurology
 HSMN NewsFeed - 13 Oct 2014
FDA Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Sep 2014
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2014
Advances in Trigeminal Nerve Stimulation Featured at European Congress on Epileptology in Stockholm, Sweden
Devices Neurology
 HSMN NewsFeed - 2 Jul 2014
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Jun 2014
Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2014
Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2014
GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss
Devices Neurology Radiology Distribution
 HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 28 Apr 2014
GW Pharmaceuticals Announces That Sativex Receives Fast Track Designation From FDA in Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 31 Mar 2014
Eisai Assigns Its Worldwide Exclusive License for DACOGEN(R) to Otsuka
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Mar 2014
Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Mar 2014
NeuroSigma Expands Its Management Team with Two Former Amgen Finance Executives
Devices Neurology Personnel
 HSMN NewsFeed - 28 Feb 2014
GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2014
David Hayes, Former Partner at O'Melveny & Myers LLP and Haynes and Boone LLP, Joins NeuroSigma As Chief Administrative Officer, General Counsel and Sr. Vice President
Devices Neurology Personnel
 HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Devices Regulatory
 HSMN NewsFeed - 19 Feb 2014
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 11 Feb 2014
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
Devices Neurology Personnel
 HSMN NewsFeed - 27 Jan 2014
Former Allergan Marketing Executive Gregory F. Brooks Joins NeuroSigma As Senior VP and Chief Commercial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Jan 2014
Eisai Announces U.S. Availability of FYCOMPA(TM) (perampanel) CIII an Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy Age 12 and Older
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 24 Dec 2013
Supernus Announces Resignation of Board Member
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Dec 2013
First U.S. Implants of New Medtronic Deep Brain Stimulation System Advance Ground-Breaking Research Into Brain Activity While Therapy Is Delivered
Devices Neurology Personalized Medicine
 HSMN NewsFeed - 27 Nov 2013
GW Pharmaceuticals plc Announces Sativex(R) Regulatory Approval in Switzerland
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 26 Nov 2013
Guri Stark Joins CorTechs Labs as CEO
Devices Radiology Personnel
 HSMN NewsFeed - 21 Nov 2013
Otsuka and Lundbeck's Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Nov 2013
Eisai Announces Availability of ACIPHEX(R) Sprinkle(TM) (Rabeprazole Sodium) for Treatment of GERD in Children Ages 1 to 11
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 22 Oct 2013
Monteris Medical Announces $13 Million Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 9 Oct 2013
electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
Devices Neurology
 HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Devices Neurology Personnel
 HSMN NewsFeed - 19 Aug 2013
Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR(TM)
Biopharmaceuticals Neurology FDA Product Launch
 HSMN NewsFeed - 8 Aug 2013
FDA Grants Orphan Drug Status To Eisai's Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Aug 2013
Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents
Biopharmaceuticals Generics Neurology Litigation
 HSMN NewsFeed - 7 Aug 2013
New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy
Devices Neurology
 HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Jul 2013
XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 8 Apr 2013
Monteris Medical’s NeuroBlate System Receives 510(k) Clearance
Devices Neurosurgery FDA
 HSMN NewsFeed - 3 Apr 2013
Monteris Medical's AutoLITT- NeuroBlate System for Brain Tumors Receives Regulatory Approval in Canada
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 26 Mar 2013
U.S. Food and Drug Administration Approves Full Expansion of BioControl Medical’s INOVATE-HF Study of the CardioFit(R)
Devices Cardiology FDA
 HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2013
FDA Advisory Panel Recommends Approval of the NeuroPace RNS(R) System for Medically Refractory Epilepsy
Devices Neurology FDA
 HSMN NewsFeed - 21 Feb 2013
Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jan 2013
Alere Executes License Agreement with Miraculins for Preeclampsia Technology
Diagnostics Licensing
 HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Devices Neurology Personnel
 HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 12 Dec 2012
Natus Comments on FDA Recall
Devices Product Recall FDA
 HSMN NewsFeed - 22 Oct 2012
Supernus Receives FDA Approval for Oxtellar XR(TM) in Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Sep 2012
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Jul 2012
Supernus Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2012
NeuroSigma Receives Global Quality Control Certification
Devices Regulatory
 HSMN NewsFeed - 21 Jun 2012
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2012
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
Devices Neurology Regulatory
 HSMN NewsFeed - 29 May 2012
Eisai Gains Positive CHMP Opinion for Fycompa(R) (perampanel) First in a New Class of Treatment for Partial Onset Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 May 2012
NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
Devices Interventional Neurology Acquisitions
 HSMN NewsFeed - 4 May 2012
Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 4 May 2012
Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2012
NeuroSigma Awarded NIH Grant for Further Development of Its Thin-Film Nitinol Covered Neurovascular Stent
Devices Neurology Interventional
 HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
Devices Neurology Personnel
 HSMN NewsFeed - 21 Mar 2012
UCLA Professor of Neurosurgery and NeuroSigma Co-Founder Honored for Groundbreaking Work including Deep Brain Stimulation for Treatment of PTSD
Devices Neurosurgery Personnel
 HSMN NewsFeed - 15 Mar 2012
Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Devices Neurology Regulatory
 HSMN NewsFeed - 28 Feb 2012
James Reinstein Appointed President and Chief Executive Officer of Aptus Endosystems
Devices Personnel
 HSMN NewsFeed - 3 Jan 2012
Cyberonics Announces FDA Approval of Re-Designed AspireHC(TM) Generator for VNS Therapy
Devices FDA
 HSMN NewsFeed - 16 Dec 2011
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2011
Catalyst Pharmaceutical Partners Promotes Alicia Grande to Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2011
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2011
Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy(R) Systems
Devices FDA
 HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Oct 2011
Cyberonics Announces Submission of AspireHC(TM) Generator for Regulatory Approvals
Devices Regulatory
 HSMN NewsFeed - 10 Oct 2011
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
Devices Personnel
 HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Sep 2011
Natus Acquires Embla Systems LLC - Leading Sleep Diagnostic Company
Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2011
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Sep 2011
ViroPharma's Buccolam(R) (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Sep 2011
Pfizer Extends Tender Offer to Acquire Icagen, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2011
NeuroLogica Corporation Receives CE Mark for Its Portable, High-Resolution SPECT Camera, the inSPira HD(TM)
Devices Radiology Neurology Regulatory
 HSMN NewsFeed - 29 Jul 2011
U.S. FDA Provides Response to Perampanel New Drug Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Jul 2011
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Devices Interventional Licensing
 HSMN NewsFeed - 21 Jun 2011
Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2011
Cerbomed: Promising Results for a Study into Using Transcutaneous Vagus Nerve Stimulation for Hard to Treat Epilepsies
Devices Neurology
 HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
Devices Neurology
 HSMN NewsFeed - 13 Jun 2011
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga (ezogabine)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2011
NeuroSigma Provides Update on Trigeminal Nerve Stimulation (TNS) - the USB Port to the Brain
Devices Neurology
 HSMN NewsFeed - 16 Mar 2011
Medtronic Announces Launch of Activa(R) SC Deep Brain Stimulation System
Devices Neurology
 HSMN NewsFeed - 9 Feb 2011
Natus Medical Appoints John T. Buhler as President and COO
Devices Personnel
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2011
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
Devices FDA
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2011
Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2011
Eisai to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Therapy for Partial Onset Seizures in Patients with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jan 2011
Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 21 Jan 2011
VIVUS Provides Regulatory Update on QNEXA NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jan 2011
Zogenix and Desitin Announce Marketing Approval for SUMAVEL(R) DosePro(TM) in Germany and the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jan 2011
Regulus Therapeutics Promotes Garry E. Menzel, Ph.D., to Chief Operating Officer and Executive Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2010
Icagen Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2010
Cyberonics Confirms Safety and Efficacy of VNS Therapy(R)
Devices Neurology
 HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2010
St. Paul Heart Clinic First in Upper Midwest to Implant New Early-Stage Heart Failure Device
Devices Cardiology
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Oct 2010
Natus Acquires Medix - Leading Newborn Care Company in Latin America
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2010
Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy
Devices Neurology Regulatory
 HSMN NewsFeed - 12 Aug 2010
Meda: Ezogabine Receives Positive Vote From FDA Advisory Committee
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2010
Cyberonics Board of Directors Nominates Jon T. Tremmel
Devices Neurology Personnel
 HSMN NewsFeed - 8 Jun 2010
Elekta Introduces Next Generation MEG System for Monitoring the Brain in Action
Devices Neurology
 HSMN NewsFeed - 7 Jun 2010
Elekta Introduces Next Generation MEG System for Monitoring the Brain in Action
Devices Neurology Monitoring
 HSMN NewsFeed - 20 May 2010
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 31 Mar 2010
Eisai Submits Marketing Authorisation Application for Approval of Eribulin Mesylate in Europe, Based on Significant Overall Survival in Late Stage Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Mar 2010
FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy
Devices Neurology FDA
 HSMN NewsFeed - 24 Feb 2010
MicroTransponder Raises $10 Million to Begin Clinical Trials of Wireless Neurostimulation for Chronic Pain and Obtain FDA Clearance
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2010
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jan 2010
Cyberonics' VNS Therapy(TM) System Receives Regulatory Approval in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 19 Jan 2010
RCT and Zassi Medical Evolutions Form Leto Medical, LLC
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2010
Natus Medical Announces Reorganization
Devices
 HSMN NewsFeed - 7 Jan 2010
Miraculins Announces Partnership With Inverness Medical Innovations to Develop a Diagnostic Test for Preeclampsia
Diagnostics
 HSMN NewsFeed - 30 Dec 2009
FDA Accepts NDA Filing for Retigabine
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Dec 2009
FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2009
Stockholders of CombinatoRx and Neuromed Vote for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Dec 2009
Louis Silverman Appointed to Questcor Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Dec 2009
Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy
Devices Neurology
 HSMN NewsFeed - 24 Nov 2009
SpineGuard elects founder of Danek Medical, Alan Olsen, as a director
Devices Radiology Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 17 Nov 2009
Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2009
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Biopharmacetuicals Onocology
 HSMN NewsFeed - 14 Oct 2009
National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
Devices Neurology
 HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Oct 2009
Cyberonics Announces Epilepsy Technology Collaborations
Devices Neurology
 HSMN NewsFeed - 14 Sep 2009
Natus Medical to Acquire Alpine Biomed
Devices Monitoring Neurology Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2009
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
Devices Neurosurgery
 HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2009
Cyberonics Provides Update on Depression Post-Approval Study
Devices Neurology FDA
 HSMN NewsFeed - 16 Jul 2009
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
Devices Neurology FDA
 HSMN NewsFeed - 6 Jul 2009
Natus Medical Acquires Hawaii Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 Jul 2009
CombinatoRx and Neuromed Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 17 Jun 2009
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2009
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 May 2009
Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
Devices Neurology Personnel
 HSMN NewsFeed - 13 May 2009
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 May 2009
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2009
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Apr 2009
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
Devices Neurology
 HSMN NewsFeed - 15 Apr 2009
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 Apr 2009
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2009
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 8 Apr 2009
Neurosurgeons from around the world gather at PLA 301 Hospital in China
Devices Surgery Neurosurgery Radiology
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 19 Feb 2009
Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 28 Jan 2009
Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 21 Jan 2009
Actavis Receives Approval of Levetiracetam Oral Solution in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Jan 2009
Astro-Med's Grass Technologies Group Receives FDA Clearance to Market Its Neurotrac(R) III Neuromonitoring System
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 16 Jan 2009
Lupin is Granted USFDA Approval for Levetiracetam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Jan 2009
FDA Advisory Committee Unanimously Recommends Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Jan 2009
Cyberonics Provides Business Update on Depression Clinical Trial
Devices Neurology FDA
 HSMN NewsFeed - 31 Oct 2008
Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
Devices Neurology Reimbursement
 HSMN NewsFeed - 24 Oct 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Oct 2008
Valeant Pharmaceuticals and GlaxoSmithKline Complete Worldwide Collaboration Agreement for Retigabine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2008
Natus Medical to Acquire Products from BrainZ Instruments Limited
Devices Monitoring Acquisitions
 HSMN NewsFeed - 1 Oct 2008
Cyberonics Provides Update on Depression Indication
Devices Neurology
 HSMN NewsFeed - 25 Sep 2008
UCB Withdraws EU Marketing Authorisation Application for Lacosamide in Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Sep 2008
Amarin Appoints Dr. Paresh Soni as SVP and Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Sep 2008
Keppra XR(TM) Approved in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 3 Sep 2008
Natus Medical to Acquire NeuroCom International
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2008
Biovail Appoints Dr. Neil M. Sussman Vice-President, Neurologic & Psychiatric Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2008
IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
Devices Radiology Surgery
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2008
Regulus Therapeutics Appoints Garry Menzel, Ph.D., as Executive Vice President Corporate Development and Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 2 Jul 2008
Natus Medical Acquires Schwarzer GmbH Neurology Division
Devices Neurology Acquisitions
 HSMN NewsFeed - 19 Jun 2008
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 May 2008
Natus Medical Completes Acquisition of Sonamed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 May 2008
New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Apr 2008
Neuromed Names Sean Cunliffe Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Natus Medical to Acquire SonaMed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Icagen Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro(TM) to Desitin Pharmaceuticals, GmbH
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 10 Mar 2008
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to Froedtert Hospital in Milwaukee
Devices Neurology
 HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
FDA Accepts for Review OVATION's Two NDA Submissions for Sabril(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Feb 2008
Integra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
Devices Neurosurgery
 HSMN NewsFeed - 12 Feb 2008
Natus Medical to Resume Domestic Shipments of Olympic Cool-Cap
Devices FDA Neurology
 HSMN NewsFeed - 11 Feb 2008
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center
Devices Neurology
 HSMN NewsFeed - 11 Feb 2008
Natus Medical Announces Integration and Restructuring
Devices
 HSMN NewsFeed - 1 Feb 2008
Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Jan 2008
Orphan Drug Designation Granted to OVATION's Clobazam for the Adjunctive Treatment of a Severe Form of Childhood Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Jan 2008
Sepracor Inc. and Bial Announce Exclusive Licensing Agreement for Development and Commercialization of Anti-Epileptic Compound in United States and Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2007
Cyberonics Licenses Obesity-Related Patents
Devices Licensing
 HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Dec 2007
Cyberkinetics Receives FDA Response Letter on Andara(TM) OFS(TM) System for Acute Spinal Cord Injury
Devices Neurology
 HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 4 Dec 2007
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2007
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Dec 2007
Researchers Report Results from Study of Brain Electrical Activity Using Cyberkinetics' NeuroPort(TM) System at the American Epilepsy Society Meeting
Devices Neurology
 HSMN NewsFeed - 3 Dec 2007
UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Nov 2007
Questcor Appoints Don M. Bailey as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2007
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Nov 2007
Natus Resumes Production and Shipping Operations at Olympic Facility
Devices
 HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Nov 2007
Questcor Appoints Stephen Farrell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Cyberkinetics and NeuroMetrix Forge Strategic Alliance and Agree to Pursue Joint Venture Aimed at Developing Andara(TM) OFS(TM) Therapy for Peripheral Nerve Injury
Devices Neurology
 HSMN NewsFeed - 14 Nov 2007
NeuroMetrix Announces Strategic Alliance with Cyberkinetics
Devices Neurology
 HSMN NewsFeed - 31 Oct 2007
Duska Therapeutics Appoints Dr. Alan J. Tuchman to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2007
UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Oct 2007
FDA Issues Approvable Letter for Stavzor(TM) Delayed Release Valproic Acid Capsules
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2007
New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Oct 2007
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Biopharmaceuticals Pain Mangement FDA
 HSMN NewsFeed - 15 Oct 2007
Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2007
Elekta: Finding Hope for Autism - New Brain Research Technology Centre Opened by HRH Princess Anne
Devices Neurology
 HSMN NewsFeed - 10 Oct 2007
Amarin Announces Initiation of Cardiovascular Development Strategy
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
Natus Medical to Acquire Excel-Tech Ltd.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Sep 2007
Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
Devices Neurosurgery Oncology
 HSMN NewsFeed - 28 Aug 2007
Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2007
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Aug 2007
Noven Completes Acquisition of JDS Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2007
Icagen Announces Investment by Pfizer
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2007
Icagen Announces Alliance with Pfizer in Ion Channel-Focused Therapeutics for Pain and Related Disorders
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2007
Cyberonics Names James A. Reinstein as Vice President, Sales & Marketing, and General Manager, International and Announces Other Management Changes
Devices Personnel
 HSMN NewsFeed - 2 Aug 2007
Neuromed Appoints Mario Orlando as Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Icagen Announces Filing of IND for ICA-105665, a Novel Compound for the Treatment of Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jul 2007
FDA Approves Demipulse and Demipulse Duo Generators
Devices Neurology FDA
 HSMN NewsFeed - 16 Jul 2007
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jun 2007
Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jun 2007
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Jun 2007
XLTEK Announces New Senior Management Appointment
Devices Personnel
 HSMN NewsFeed - 13 Jun 2007
Bradley Pharmaceuticals Announces Launch of Elestrin(TM)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
Washington Hospital Healthcare System First in the United States to Treat Patients Using the New Leksell(R) Gamma Knife Perfexion(TM)
Devices Oncology Neurosurgery
 HSMN NewsFeed - 4 Jun 2007
PET/CT: The Best Test for Women With Ovarian Cancer
Devices Radiology Oncology
 HSMN NewsFeed - 30 May 2007
Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 21 May 2007
Siemens Demonstrates World's First System Capable of Simultaneous Imaging of the Brain by MRI and PET
Devices Radiology
 HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 May 2007
NeuroVista Raises $33.8 Million in Series B Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 8 May 2007
XLTEK Provides Update on Market Developments for its Front-Line NeuroPATH Product
Devices Diagnostics Neurology Reimbursement
 HSMN NewsFeed - 2 May 2007
Dr. John P. Donoghue Presents on Cyberkinetics' BrainGate Neural Interface System in Plenary Session at the AAN Annual Meeting in Boston
Devices Neurology
 HSMN NewsFeed - 1 May 2007
New Data Shows Once a Day Lamictal(R) XR(TM) Is Effective in Treating Patients With Partial Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 May 2007
Cyberonics Announces Organizational Restructuring
Devices Neurology
 HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Devices Neurology Personnel
 HSMN NewsFeed - 30 Apr 2007
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
Devices Neurosurgery Oncology
 HSMN NewsFeed - 27 Apr 2007
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Apr 2007
Natus Medical Signs Three-Year Supplier Contracts with Premier, Inc.
Devices Group Purchasing
 HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Mar 2007
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
Devices Neurology
 HSMN NewsFeed - 6 Mar 2007
Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
Biopharmaceuticals Drug Delivery Neurology Licensing
 HSMN NewsFeed - 2 Mar 2007
Abbott Canada Launches Oscient Pharmaceuticals' FACTIVE Tablets in Canada
Biopharmacetuicals
 HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Feb 2007
Cyberkinetics Files to Market Andara(TM) OFS(TM) Therapy for Acute Spinal Cord Injury under Humanitarian Device Exemption
Devices Neurology Regenerative Medicine FDA
 HSMN NewsFeed - 12 Feb 2007
Ardea Biosciences Announces New Corporate Headquarters, New Ticker Symbol, and Appointment of Key R&D Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Centers for Medicare and Medicaid Services (CMS) Declines Cyberonics' Formal Request to Expand Coverage of VNS Therapy
Devices Reimbursement
 HSMN NewsFeed - 5 Feb 2007
Europe's First Trilogy Tx System to Offer New Hope for Irish Cancer Patients
Devices Oncology
 HSMN NewsFeed - 1 Feb 2007
Anavex Life Sciences Corp. Outlines Its Central Nervous System (CNS) Portfolio of Novel Therapeutics
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jan 2007
Icagen Announces $22 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Jan 2007
Valeant Pharmaceuticals Developing Intranasal Diazepam for the At-Home Treatment of Emergency Seizures
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 16 Jan 2007
More European Patients With Epilepsy to Benefit From Keppra(R)
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 3 Jan 2007
D-Pharm Announces Positive Phase IIb Trial Results for DP-b99 in Acute Stroke Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Dec 2006
Natus Medical Receives FDA Approval for the Olympic Cool-Cap
Devices FDA Neurology
 HSMN NewsFeed - 15 Dec 2006
Caraco Pharmaceutical Laboratories Ltd. to Market Extended Phenytoin Sodium Capsules, USP 100mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Dec 2006
XLTEK Announces New Senior Management Appointment
Devices Personnel
 HSMN NewsFeed - 4 Dec 2006
NBI Development Closes $5.5 Million in Seed Round Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 4 Dec 2006
Phase II Data Shows Ovation's Novel Compound Clobazam to Be Well Tolerated in Patients With Catastrophic Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Nov 2006
Eisai Recieves Positive Opinion for Inovelon(R) Marketing Authorization from European Committee for Medicinal Products for Human Use (CHMP)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 17 Nov 2006
Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2006
Natus Medical Announces Introduction of BioMAP Software for Navigator Pro AEP System
Devices
 HSMN NewsFeed - 24 Oct 2006
U.S. District Court Grants Request for Preliminary Injunction to Ortho-McNeil Neurologics, Inc. for TOPAMAX(R)
Biopharmaceuticals Neurology Generics Litigation
 HSMN NewsFeed - 16 Oct 2006
Natus Medical to Acquire Olympic Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Oct 2006
Neurotechnology Industry Organization Launched to Advance Treatments for Brain and Nervous System Illnesses
Devices Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Oct 2006
Elekta Wins Tender to Deliver Sophisticated 3-D Brain Mapping Technology to Leading German Institution
Devices Neurology
 HSMN NewsFeed - 28 Sep 2006
New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Sep 2006
FDA Approves New Epilepsy Indication For Lamictal(R)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Sep 2006
Pfizer's Lyrica(R) Approved in Europe for Difficult-to-Treat Nerve Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Sep 2006
Icagen Reports Results of Data Monitoring Committee Meeting in Phase III Assert Trial of ICA-17043
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2006
Cyberonics Provides TRD Post Approval Patient Access and Outcomes Update
Devices Neurology
 HSMN NewsFeed - 6 Sep 2006
Natus Medical to Acquire DELTAMED
Devices Mergers & Acquisitions
 HSMN NewsFeed - 23 Aug 2006
FDA Approves Keppra(R) as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Aug 2006
Questcor Files sNDA for Treatment of Infantile Spasms with H.P. Acthar(R) Gel
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Aug 2006
FDA Approves Keppra(R) Intravenous Formulation
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2006
New Data Demonstrate Effectiveness of LAMICTAL(R) (lamotrigine) as Adjunctive Therapy for Children and Adolescents With Primary Generalized Tonic-Clonic (PGTC) Seizures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jul 2006
University of Florida Physicians Are First to Deliver Stereotactic Radiosurgery Treatments Using Trilogy Tx(TM) From Varian Medical Systems
Devices Oncology Neurosurgery
 HSMN NewsFeed - 28 Jul 2006
Pfizer Board of Directors Names Jeffrey B. Kindler Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2006
Exelon(R) Patch, the first transdermal therapy for Alzheimer's disease, may provide a promising new approach to treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jul 2006
Cyberonics Receives FDA Approval for Harmonized/Modularized VNS Therapy System Labeling Format
Devices FDA Neurology
 HSMN NewsFeed - 11 Jul 2006
IMPAX Announces the Launch of IMPAX Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2006
Philips and Dartmouth Announce Research Collaboration to Advance Discovery in Cancer, Heart, and Neurological Diseases
Devices Radiology
 HSMN NewsFeed - 3 Jul 2006
A Key Regulatory Milestone for Keppra
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 27 Jun 2006
The U.S. Food and Drug Administration Approves Exelon(R) (rivastigmine tartrate) as the First Medication Indicated to Treat Parkinson's Disease Dementia
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 26 Jun 2006
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2006
Pfizer Enters Into Agreement with Bayer to License Compounds for Potential Treatment of Obesity, Diabetes and Related Disorders
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Jun 2006
NPS Announces Aggressive Plan to Restructure Operations and Cut Costs
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2006
Icagen Names Senior Vice President Clinical and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2006
Cyberonics Provides Update on Annual American Psychiatric Association Meeting Activities and Recent VNS Therapy Publications
Devices Neurology
 HSMN NewsFeed - 19 May 2006
Elekta Convenes 300 Neurosurgeons, Radiation Oncologists and Leksell Gamma Knife(R) Users in Seoul, Korea
Devices Oncology Neurosurgery
 HSMN NewsFeed - 17 May 2006
FDA Advisory Committee Recommends Approval of Exelon(R) (rivastigmine tartrate) in the Treatment of Dementia Associated with Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2006
Cyberonics Announces Patient Enrollment in New TRD Dosing Study
Devices Neurology
 HSMN NewsFeed - 15 May 2006
European Commission Approves Keppra(R) for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 9 May 2006
Philips extends global leadership in ultra high-field MR with 7.0T whole body scanner research contracts
Devices Radiology Neurology
 HSMN NewsFeed - 5 May 2006
Questcor Announces the Acquisition of Doral(R) (quazepam)
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 3 May 2006
IDev Technologies, Inc. Announces the Hiring of a New Executive Management Team
Devices Interventional Personnel
 HSMN NewsFeed - 1 May 2006
Cyberonics Announces 1,100th Patient Treated With VNS Therapy(tm) for Treatment-Resistant Depression (TRD) Since FDA Approval
Devices Neurology
 HSMN NewsFeed - 28 Apr 2006
Cyberonics Announces Launch of TRD Patient Registry
Devices Neurology
 HSMN NewsFeed - 26 Apr 2006
UCB: Two European Regulatory Milestones for Keppra(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2006
Medtronic Announces Clinical Trials Strategy for Neurological and Urological Therapies
Devices Urology Neurology
 HSMN NewsFeed - 10 Apr 2006
Neuromed Pharmaceuticals Appoints Former Pfizer Senior Manager to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2006
SCHWARZ PHARMA Presents Clinical Data on Rotigotine Transdermal Patch at the Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 27 Mar 2006
Pfizer's Lyrica Approved for the Treatment of Generalized Anxiety Disorder (GAD) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Mar 2006
VistaGen Therapeutics and Cato BioVentures Sign Strategic Business Development Agreement for CNS Products
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Mar 2006
Neuromed Pharmaceuticals and Merck & Co., Inc. Announce Agreement for Novel N-type Calcium Channel Compounds
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 8 Mar 2006
Myriad Pharmaceuticals, Inc. Names Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2006
Xyrem(R) (Sodium Oxybate) Now Available for the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Narcolepsy
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2006
UCB Receives EMEA Positive Opinion and FDA Approvable Letter for Keppraź (levetiracetam) Intravenous Administration
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 2 Feb 2006
Hanger Orthopedic Group Gains FDA Approval, Announces New Management Team of Subsidiary Innovative Neurotronics
Devices FDA Personnel
 HSMN NewsFeed - 31 Jan 2006
Mark A. Varney, Ph.D. Named Chief Operating Officer and Chief Scientific Officer of Cortex Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2006
Pfizer's Lyrica Receives Positive Opinion From CHMP for the Treatment of Generalized Anxiety Disorder in Adults
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jan 2006
Neurologix Announces Appointment of Marc Panoff as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2006
CepTor Receives Dual Orphan Drug Designation for Myodur (C101) for Duchenne and Becker Muscular Dystrophies
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Jan 2006
Shire and Impax Settle all Pending Litigation Concerning ADDERALL XR(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Jan 2006
Cyberonics Announces Closure of Investigational Device Exemption (IDE) for Treatment-Resistant Depression (TRD), Lifetime Reimbursement Guarantee for All TRD IDE Study Patients and $15 Million TRD Indigent Care Program
Devices Neurology Reimbursement
 HSMN NewsFeed - 17 Jan 2006
CepTor Submits Investigational New Drug Application (IND) to Initiate Clinical Trials with Myodur (C-101) in Duchenne Muscular Dystrophy (DMD) Patients
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Jan 2006
King Pharmaceuticals Commences Phase III Clinical Trial Evaluating Vanquix(R) as a Treatment for Acute, Repetitive Epileptic Seizures
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 223

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 223 additional stories matching:
epilepsy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.